CIGI vs SBRA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
CIGI shows bearish fundamentals based on deterministic rules. Financial strength is stable (F-Score 4/9). Concerns include weak profitability or high valuation.
SBRA presents a precarious financial profile with a Piotroski F-Score of 4/9, indicating only stable, non-strong health. The stock is trading at a severe premium to both its Graham Number ($12.71) and Intrinsic Value ($4.48), while maintaining a dangerous dividend payout ratio of 187.5%. Despite double-digit revenue growth, the company is experiencing a sharp contraction in earnings (-44.7% YoY), suggesting a fundamental disconnect between top-line growth and profitability. The combination of bearish technicals, negative insider sentiment, and unsustainable dividends suggests a value trap despite optimistic analyst targets.
Compare Another Pair
Related Comparisons
CIGI vs SBRA: Head-to-Head Comparison
This page compares Colliers International Group Inc. (CIGI) and Sabra Health Care REIT, Inc. (SBRA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.